۱۳۹۶/۰۵/۰۲ (تعداد بازدید : ۲۴۰۴)نویسنده :
EUROPEAN JOURNAL OF NEUROLOGY
Volume ۲۴, Supplement ۱, June ۲۰۱۷
Abstracts of the ۳rd Congress of the European Academy of Neurology
Amsterdam, The Netherlands
Observational cohort study on safety and efficacy of copamer (a new brand-generic
Glatiramer acetate) ۴۰mg in Iranian patients with RRMS
R. Abolfazli۱, S. Pournourmohammadi۲, S. Samadzadeh۱,A.R. Shamshiri۳, J. Alaghehmandi۲
۱Amiralam hospital, ۲Zahravi Pharmaceutical Company, Tehran, Iran, Islamic Republic of, ۳School of
Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Objective: The aim of this study is to evaluate the safety, tolerability and efficacy of a brand-generic Glatiramer acetate (GA) ۴۰ mg, in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) over a ۱۲-month period.
بیشتر بخوانید